drugset / Trial / NCT05891886

Supplemental Oxygen in Pulmonary Embolism (SO-PE)

NCT05891886

RandomizedCrossoverSingle-blindOther

Summary

A study of how supplemental oxygen helps patients with acute pulmonary embolism (PE). Hypothesis: Oxygen affects right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (PE) primarily by relieving hypoxic pulmonary vasoconstriction and reducing pulmonary pressure (PA) pressure, and that this process is metabolically driven.

Timeline

Start
2023-10-01
Primary completion
2027-06-30
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified 60 % Inhaled